ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,027 | 2,250 | -1,076 | 8,553 | 3,833 |
| Depreciation Amortization | 16,508 | 8,195 | 27,928 | 20,906 | 13,807 |
| Income taxes - deferred | -987 | -496 | 3,560 | -4,602 | -1,706 |
| Accounts receivable | 2,673 | 3,987 | -12,893 | -16,279 | -9,618 |
| Other Working Capital | 2,244 | 9,497 | -5,652 | -11,634 | -16,387 |
| Other Operating Activity | 6,058 | -503 | 27,552 | 26,670 | 16,601 |
| Operating Cash Flow | $31,523 | $22,930 | $39,419 | $23,614 | $6,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,364 | -2,278 | -10,369 | -6,922 | -4,442 |
| Purchase Sale Intangibles | -5,169 | 0 | -97,624 | -50,956 | -50,956 |
| Other Investing Activity | -5,169 | 0 | -97,624 | -50,956 | -50,956 |
| Investing Cash Flow | $-8,533 | $-2,278 | $-107,993 | $-57,878 | $-55,398 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 25,000 | 30,000 |
| Debt Issued | N/A | N/A | 75,000 | N/A | N/A |
| Debt Repayment | -938 | -938 | N/A | 0 | 0 |
| Common Stock Issued | 2,611 | 1,511 | 353 | 191 | 131 |
| Common Stock Repurchased | -659 | -250 | -259 | -259 | -259 |
| Other Financing Activity | -153 | -153 | -2,737 | 0 | 0 |
| Financing Cash Flow | $861 | $170 | $72,357 | $24,932 | $29,872 |
| Beginning Cash Position | 36,150 | 36,150 | 32,367 | 32,367 | 32,367 |
| End Cash Position | 60,001 | 56,972 | 36,150 | 23,035 | 13,371 |
| Net Cash Flow | $23,851 | $20,822 | $3,783 | $-9,332 | $-18,996 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,523 | 22,930 | 39,419 | 23,614 | 6,530 |
| Capital Expenditure | -3,364 | -2,278 | -10,369 | -6,922 | -4,442 |
| Free Cash Flow | 28,159 | 20,652 | 29,050 | 16,692 | 2,088 |